Compugen Ltd. (NASDAQ: CGEN) kicked off on January 24, 2023, at the price of $0.8407, up 2.15% from the previous trading day. During the day, the shares moved up to $0.91 and dropped to $0.835 before settling in for the closing price of $0.86. Over the past 52 weeks, CGEN has traded in a range of $0.51-$3.84.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Annual sales at Healthcare sector company grew by 53.20% over the past five years. While this was happening, its average annual earnings per share was recorded -8.90%. With a float of $81.78 million, this company’s outstanding shares have now reached $86.62 million.
Let’s look at the performance matrix of the company that is accounted for 73 employees.
Compugen Ltd. (CGEN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Compugen Ltd. is 12.00%, while institutional ownership is 26.30%.
Compugen Ltd. (CGEN) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 6/29/2022, the organization reported -$0.11 earnings per share (EPS), higher than consensus estimate (set at -$0.12) by $0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.90% per share during the next fiscal year.
Compugen Ltd. (NASDAQ: CGEN) Trading Performance Indicators
Take a look at Compugen Ltd.’s (CGEN) current performance indicators. Last quarter, stock had a quick ratio of 6.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Compugen Ltd. (CGEN)
Compugen Ltd. (NASDAQ: CGEN) saw its 5-day average volume 0.89 million, a positive change from its year-to-date volume of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 19.62%. Additionally, its Average True Range was 0.10.
During the past 100 days, Compugen Ltd.’s (CGEN) raw stochastic average was set at 51.00%, which indicates a significant increase from 37.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.37% in the past 14 days, which was lower than the 113.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9181, while its 200-day Moving Average is $1.3979. Nevertheless, the first resistance level for the watch stands at $0.9165 in the near term. At $0.9508, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9915. If the price goes on to break the first support level at $0.8415, it is likely to go to the next support level at $0.8008. Assuming the price breaks the second support level, the third support level stands at $0.7665.
Compugen Ltd. (NASDAQ: CGEN) Key Stats
The company with the Market Capitalisation of 73.34 million has total of 86,625K Shares Outstanding. Its annual sales at the moment are 6,000 K in contrast with the sum of -34,200 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -11,748 K.